3. Summary
Global Market Direct’s pharmaceuticals report, “Cancer Therapeutics CRC Pty
Ltd - Product Pipeline Review - 2012” provides data on the Cancer Therapeutics
CRC Pty Ltd’s research and development focus. The report includes information
on current developmental pipeline, complete with latest updates, and features
on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets
Direct’s proprietary databases, Cancer Therapeutics CRC Pty Ltd’s corporate
website, SEC filings, investor presentations and featured press releases, both
from Cancer Therapeutics CRC Pty Ltd and industry-specific third party sources,
put together by Global Markets Direct’s team.
4. Scope
- Cancer Therapeutics CRC Pty Ltd - Brief Cancer Therapeutics CRC Pty Ltd overview
including business description, key information and facts, and its locations and
subsidiaries.
- Review of current pipeline of Cancer Therapeutics CRC Pty Ltd human therapeutic
division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Reasons to buy
- Evaluate Cancer Therapeutics CRC Pty Ltd’s strategic position with total access to
detailed information on its product pipeline.
- Assess the growth potential of Cancer Therapeutics CRC Pty Ltd in its therapy areas
of focus.
- Identify new drug targets and therapeutic classes in the Cancer Therapeutics CRC
Pty Ltd’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in
those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill
portfolio gaps.
5. Table of Contents :
List of Tables 4
List of Figures 4
Cancer Therapeutics CRC Pty Ltd Snapshot 5
Cancer Therapeutics CRC Pty Ltd Overview 5
Key Information 5
Key Facts 5
Cancer Therapeutics CRC Pty Ltd – Research and Development Overview 6
Key Therapeutic Areas 6
Cancer Therapeutics CRC Pty Ltd – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Pipeline Products – Combination Treatment Modalities 11
Cancer Therapeutics CRC Pty Ltd – Pipeline Products Glance 12
Cancer Therapeutics CRC Pty Ltd – Early Stage Pipeline Products 12
Pre-Clinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Cancer Therapeutics CRC Pty Ltd – Drug Profiles 14
CTX-0294945 + Avastin 14…………..
6. Please follow link if you want More Related
Reports :
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product
Pipeline Review&PubId=&pagenum=1